Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Operating Expenses | 27,860 | 12,041 | 22,641 | 8,133 | 21,218 |
| Operating Income | -27,860 | -12,041 | -22,641 | -8,133 | -21,218 |
| Interest Expense | 0 | 0 | 445 | 1,922 | 152 |
| Other Income | 200 | 6 | -2,296 | 6,747 | -4,324 |
| Pre-tax Income | -27,660 | -12,035 | -25,382 | -3,308 | -25,694 |
| Net Income Continuous | -27,660 | -12,035 | -25,382 | -3,308 | -25,694 |
| Net Income | $-27,660 | $-12,035 | $-25,382 | $-3,308 | $-25,694 |
| EPS Basic Total Ops | -0.62 | -0.48 | -3.47 | -4.14 | -34.00 |
| EPS Basic Continuous Ops | -0.62 | -0.48 | -2.60 | -4.14 | -33.84 |
| EPS Diluted Total Ops | -0.62 | -0.48 | -3.47 | -4.14 | -34.00 |
| EPS Diluted Continuous Ops | -0.62 | -0.48 | -2.60 | -4.14 | -33.84 |
| EBITDA(a) | $-26,861 | $-11,953 | $-22,634 | $-7,628 | $-16,216 |